Ascendiant Capital maintient son achat sur Allarity Therapeutics et augmente l'objectif de cours à 9,75 $. | Benzinga France
Crude Oil Down 2%; US Durable Goods Orders Decline In July - Domo (NASDAQ:DOMO), Allarity Therapeutics (NASDAQ:ALLR)
US Stocks Mixed; American Woodmark Posts Downbeat Sales - American Woodmark (NASDAQ:AMWD), Allarity Therapeutics (NASDAQ:ALLR)